PIC/S Adopts New Guide On Cross-Contamination, Transposes EU GMP Requirements
Executive Summary
The group representing international pharmaceutical inspectorates, PIC/S, has issued new guidance on controlling cross-contamination in shared facilities. It has also transposed several EU guidelines on good manufacturing practice that non-EEA participating authorities can adopt on a voluntary basis.
You may also be interested in...
UK Identifies Critical Failures In Cross-Contamination Control Strategies
The UK Medicines and Healthcare products Regulatory Agency is urging companies to review their strategies on preventing cross-contamination in shared manufacturing facilities in light of recent critical findings during inspections.
PIC/S Supplements GMP Guidance On Cross Contamination In Shared Facilities
The international group of pharmaceutical inspectorates, PIC/S, has issued an aide-memoire and a Q&A document to support its 2018 guideline on using health-based exposure limits to assess the risk of cross contamination in shared manufacturing facilities.
EMA Takes Flexible Approach In Setting Exposure Limits for Drugs Produced In Shared Facilities
The European Medicines Agency on April 30 issued a